英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
uterinus查看　uterinus　在百度字典中的解释百度英翻中〔查看〕
uterinus查看　uterinus　在Google字典中的解释Google英翻中〔查看〕
uterinus查看　uterinus　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • Cafepharma - Home | pharma sales, device sales, lab sales | Cafepharma
    🎧 CP Midday Brief: Novartis Spends Billions As Novo Defends Wegovy 🎧 CP Midday Brief: Triple Agonists and Indian Weight Loss Generics 🎧 CP Midday Brief: Big Pharma Lawsuits and Patent Cliffs Biopharma in depth — February 27, 2026
  • Novartis | Cafepharma
    Novartis may be launching an array of vehicles to shuttle drugs across the blood-brain barrier, but executives told Fierce that the Swiss pharma is “always looking” for new ways to traverse this final frontier of neuroscience
  • ofatumumab | Cafepharma
    Novartis will have to wait a little longer to see if the U S Food and Drug Administration (FDA) will greenlight Arzerra (ofatumumab) as a treatment for patients with relapsing multiple sclerosis (RMS) On Tuesday, the FDA extended its review of the Supplemental Biologics License Application for Arzerra in this indication by three months Regulatory action is now expected in September 2020
  • Novartis | Cafepharma Message Boards | Pharma Sales, Device Sales, Lab . . .
    Anonymous board for Novartis
  • Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
    Anonymous discussion boards for pharmaceutical sales, medical device sales, lab diagnostics sales
  • Novartis, amid reorg, cuts ‘select number’ of biomedical research roles
    After a series of staff consolidation moves in recent weeks, Novartis is again trimming its ranks, albeit in what appears to be a more limited move centered on the Swiss drugmaker’s biomedical research arm After rumors circulated on social media that Novartis was carrying out a new reduction
  • Cabaletta Bio | Cafepharma
    A quiet revolution is under way in Car-T therapy, and it has nothing to do with oncology The low-hanging fruit on that particular tree having now been picked, numerous companies are betting that autoimmune diseases could open up a new avenue of revenue generation – apparently on the strength of an academic paper Perhaps the strongest signal here was sent by Novartis, whose chief executive
  • Novartis joins Lilly, AZ in China expansion with $480M commitment to . . .
    Amid an outpouring of pharma investment dollars into China, Novartis is the latest multinational drugmaker lining up to bolster its research and production operations in the country The Swiss pharma will collectively invest more than 3 3 billion Chinese yuan (roughly $480 million) to soup up
  • layoffs | Cafepharma
    Novartis is continuing to trim its workforce in the U S , letting go of 76 employees in East Hanover, New Jersey, according to a Worker Adjustment and Retraining Notification (WARN) Act alert for the state The layoffs will take effect on Aug 21
  • BenevolentAI | Cafepharma
    The cuts keep coming at BenevolentAI Eleven months after restructuring, the AI-enabled drug developer is pulling another pivot, axing plans to launch software products, laying off another 30% of staff and closing its U S office Source Fierce Biotech Headline BenevolentAI lays off 30% of staff, exits US site as funding gap looms News Tags BenevolentAI drug development layoffs





中文字典-英文字典  2005-2009